Topic overview

Start with the big picture

Agents such as gentamicin, tobramycin, amikacin, streptomycin, and neomycin bind irreversibly to the 30S ribosomal subunit, causing mRNA misreading and blocking initiation. Their oxygen-dependent uptake explains why they are inactive against anaerobes and perform poorly in low-oxygen, acidic sites. They are potent against aerobic Gram-negative bacilli and may be combined with other antibiotics for synergy. Aminoglycosides are generally given by injection, with renal elimination and dose adjustment in renal impairment. Major risks include nephrotoxicity, often reversible, and potentially irreversible auditory or vestibular toxicity; neuromuscular blockade is another concern. The deeper lesson connects these mechanisms and pharmacologic properties with monitoring, resistance, and selected clinical indications.